AEterna Zentaris Inc $1.28

down -0.04


21/8/2014 03:59 PM  |  NASDAQ : AEZS  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get AEZS Trend Analysis - it has underperformed the S&P 500 by 25%

Partner Headlines

  1. UPDATE: H.C. Wainwright Initiates Coverage On AEterna Zentaris

    Benzinga
  2. Morning Market Losers

    Benzinga
  3. Aeterna Zentaris Announces Proposed Unit Offering; Pricing, Number of Units ...

    Benzinga
  4. Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing ...

    Benzinga
  5. Aeterna Zentaris Names Dr. Richard Sachse as Chief Scientific Officer

    Benzinga
  6. Stocks Hitting 52-Week Lows

    Benzinga
  7. Morning Market Losers

    Benzinga
  8. Aeterna Zentaris Prices 13.1M Unit Offering at $1.15/Unit

    Benzinga
  9. Billionaires Hold Waning Biotechs 42% Off

    GuruFocus
  10. Aeterna Zentaris Closes Transfer of Cetrotide Rights to Merck

    Benzinga
  11. UPDATE: Canaccord Genuity Reiterates Hold Rating, Raises PT on AEterna ...

    Benzinga
  12. Mid-Day Market Movers

    Benzinga
  13. Benzinga's Top Pre-Market Gainers

    Benzinga
  14. Aeterna Zentaris Granted SPA by FDA for Phase 3 AEZS-108 Registration Trial ...

    Benzinga
  15. Benzinga's Top Pre-Market Gainers

    Benzinga
  16. Aeterna Zentaris Announces Final Phase 2 Data for Perifosine in Lymphomas ...

    Benzinga
  17. Aeterna Zentaris Presents Promising Results for Disorazol Z Cytotoxic Conjugates

    Benzinga
  18. Stocks Hitting 52-Week Lows

    Benzinga
  19. Aeterna Zentaris Regains Compliance with NASDAQ $1.00 Minimum Bid Price ...

    Benzinga
  20. Aeterna Zentaris Announces Pricing of US $16.5 Million Public Offering ...

    Benzinga
  21. Benzinga's Top Pre-Market Losers

    Benzinga
  22. Aeterna Zentaris Announces Proposed Public Offering of Common Shares and ...

    Benzinga
  23. Benzinga's Microcap Movers for Thursday September 20, 2012

    Benzinga
  24. Benzinga's Microcap Movers for Monday August 14, 2012

    Benzinga
  25. Aeterna Zentaris Granted Patent in the U.S. for AEZS-130 as Diagnostic ...

    Benzinga
  26. Six Flags Entertainment, Sanmina-SCI Corporation Among Stocks Gapping Up ...

    FoxBusiness
  27. Aeterna Zentaris Requests Fast Track Designation from the FDA for AEZS-13 ...

    Benzinga
  28. Benzinga's Microcap Movers for Tuesday June 26, 2012

    Benzinga
  29. Aeterna Zentaris Announces Final Phase 3 Results for AEZS-130 in Adult ...

    Benzinga
  30. Aeterna Zentaris: Phase 1 Results Show Perifosine's Activity Against Neuroblastoma

    Benzinga
  31. Aeterna Zentaris Receives Notification from NASDAQ Relating to Minimum ...

    Benzinga
  32. Keryx Biopharma Trade Lower after Adam Feuerstein's Negative Blog Post

    Benzinga
  33. Aeterna Zentaris Reports Updated Phase 1 Trial Results for AEZS-108 in ...

    Benzinga
  34. Oppenheimer Reduces AEterna Zentaris PT

    Benzinga
  35. Aeterna Zentaris Announces "At-the-Market" Issuance Program of up to $16M

    Benzinga
Trading Center